Generate Biomedicines is an innovative therapeutics company that operates at the intersection of machine learning, biological engineering, and medicine. Founded in 2018 by Flagship Pioneering, the company is pioneering Generative Biology™ to computationally generate breakthrough medicines rather than discovering them through traditional methods. With a robust machine learning-powered biomedicines platform, Generate Biomedicines aims to transform the biotherapeutic development landscape and improve the lives of billions of patients. The company has secured nearly $700 million in funding and employs over 300 individuals across its offices in Somerville and Andover, Massachusetts.